You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 84 No. 3, September 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

II. The Pathogenesis of Recurrent Immunologic (Auer) Uveitis

Charles N. Gamble, MD; Samuel B. Aronson, MD; Frances B. Brescia

Arch Ophthalmol. 1970;84(3):331-341.


Abstract

These experiments clearly demonstrate the causal role of circulating antigen-antibody complexes in recurrent immunologic (Auer) uveitis and allow a precise definition of the pathogenesis of this experimental model and its extrapolation to attempt to explain the development of recurrent uveitis in man. Severe primary inflammation of the uveal tract, regardless of etiology, causes a persistent increase in uveal vascular permeability. This in turn results in the selective deposition of circulating antigen-antibody complexes in the uveal tract when conditions are favorable to the formation of immune complexes in the circulation. The presence of complexes in the uveal tissues attracts numerous polymorphonuclear leukocytes to the site resulting in the development of an acute, recurrent uveitis which is usually self-limited but which may persist or repeatedly recur, with eventual severe chronic sequelae and blindness.



Author Affiliations

San Francisco

From the Department of Pathology and Laboratory of Ocular Inflammatory Disease, Department of Ophthalmology, University of California School of Medicine, San Francisco.


Footnotes

Submitted for publication Dec 12, 1969.

Reprint requests to Department of Laboratory Medicine, Sutter Memorial Hospital, 52nd and F streets, Sacramento, Calif 95819 (Dr. Gamble).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Iris nodules associated with infectious uveitis
Myers et al.
Br J Ophthalmol 2002;86:969-974.
ABSTRACT | FULL TEXT  

Ocular Inflammatory Effects of Intravitreal Interleukin 1
Rosenbaum et al.
Arch Ophthalmol 1987;105:1117-1120.
ABSTRACT  

Early-Onset Pauciarticular Juvenile Rheumatoid Arthritis: A Histopathologic Study
Merriam et al.
Arch Ophthalmol 1983;101:1085-1092.
ABSTRACT  

Why HLA-B27: An Analysis Based on Two Animal Models
ROSENBAUM
ANN INTERN MED 1981;94:261-263.
ABSTRACT  

Vitrectomy in Experimental Uveitis: II. Method in Eyes With Protein-Induced Uveitis
Kaplan et al.
Arch Ophthalmol 1979;97:336-339.
ABSTRACT  

The Structural Basis of Altered Vascular Permeability Following Intraocular Inflammation
Howes and Cruse
Arch Ophthalmol 1978;96:1668-1676.
ABSTRACT  

Immunosuppressive Therapy for Severe Chronic Uveitis
Andrasch et al.
Arch Ophthalmol 1978;96:247-251.
ABSTRACT  

Pharmacology and Pathophysiology of Inflammation
Richardson
Arch Ophthalmol 1971;86:706-724.
 

The Uvea
Schlaegel
Arch Ophthalmol 1971;85:624-635.
 

Altered Vascular Permeability in Ocular Inflammatory Disease
Aronson et al.
Arch Ophthalmol 1971;85:455-466.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.